World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
132
Citations
73450
World Ranking
2296
National Ranking
1298

Overview

H. Joachim Deeg is affiliated with the Fred Hutchinson Cancer Research Center in the United States and focuses on medical research primarily related to hematology and oncology. Their work spans areas such as hematopoietic stem cell transplantation and leukemia, with a significant number of publications dedicated to these fields.

Their research contributions cover multiple subfields, including:

  • Hematology
  • Genetics
  • Public Health, Environmental and Occupational Health
  • Molecular Biology
  • Oncology

Major topics of study include:

  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia Research
  • Cancer Genomics and Diagnostics
  • Eosinophilic Disorders and Syndromes

Deeg has published extensively in various medical and clinical journals. Frequent publication venues consist of:

  • Blood
  • Transplantation and Cellular Therapy
  • Leukemia
  • Blood Advances
  • Bone Marrow Transplantation

Recent notable papers include:

  • "Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts", 2020, Annals of Internal Medicine
  • "Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms", 2021, Leukemia
  • "Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial", 2021, Transplantation and Cellular Therapy
  • "Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes", 2022, Journal of Clinical Oncology
  • "NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022", 2022, Journal of the National Comprehensive Cancer Network

Collaboration plays an important role in their research, working frequently with co-authors such as:

  • Amy E. DeZern
  • Aref Al-Kali
  • Salman Fazal
  • Wael Saber
  • Guillermo Garcia-Manero

Collectively, these elements illustrate H. Joachim Deeg's extensive involvement in advancing understanding and treatment of hematologic malignancies, with a focus on stem cell transplantation and leukemia-related disorders.

Best Publications

  • Massively parallel digital transcriptional profiling of single cells

    Grace X. Y. Zheng;Jessica M. Terry;Phillip Belgrader;Paul Ryvkin

  • Graft-versus-host disease

    J. L. M. Ferrara;H. J. Deeg

  • Myelodysplastic Syndromes

    H. Joachim Deeg;S.D. Gore;David T. Bowen;Steven D. Gore

  • Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

    Rainer Storb;H. Joachim Deeg;John Whitehead;Frederick Appelbaum

  • Solid Cancers after Bone Marrow Transplantation

    Rochelle E. Curtis;Philip A. Rowlings;H. Joachim Deeg;Donna A. Shriner

  • Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.

    Rainer Storb;Cong Yu;John L. Wagner;H. Joachim Deeg

  • A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

    Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg

  • Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation

    JE Sanders;J Hawley;W Levy;T Gooley

  • Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

    Rochelle E. Curtis;Lois B. Travis;Philip A. Rowlings;Gérard Socié

  • Effects of In Vitro Depletion of T Cells in HLA-Identical Allogeneic Marrow Grafts

    PJ Martin;JA Hansen;CD Buckner;JE Sanders

  • Marrow Transplantation for the Treatment of Chronic Myelogenous Leukemia

    E D Thomas;R A Clift;A Fefer;F R Appelbaum

  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

    Bart L. Scott;Marcelo C. Pasquini;Brent R. Logan;Juan Wu

  • Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.

    R Storb;HJ Deeg;M Pepe;F Appelbaum

  • Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1–risk myelodysplastic syndromes with karyotypes other than deletion 5q

    Azra Raza;James A. Reeves;Eric J. Feldman;Gordon W. Dewald

  • SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

    Eunhee Kim;Janine O. Ilagan;Yang Liang;Gerrit M. Daubner

  • Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy

    Peter Mauch;Louis Constine;Joel Greenberger;William Knospe

  • How I treat refractory acute GVHD

    H. Joachim Deeg

  • Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

    Mohamed L. Sorror;Brenda M. Sandmaier;Barry E. Storer;Michael B. Maris

  • Marrow Transplantation for Chronic Myeloid Leukemia: A Randomized Study Comparing Cyclophosphamide and Total Body Irradiation With Busulfan and Cyclophosphamide

    RA Clift;CD Buckner;ED Thomas;WI Bensinger

  • Solid cancers after allogeneic hematopoietic cell transplantation

    J. Douglas Rizzo;Rochelle E. Curtis;Gérard Socié;Kathleen A. Sobocinski

Frequent Co-Authors

Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Brenda M. Sandmaier
Brenda M. Sandmaier Fred Hutchinson Cancer Research Center
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
Ted Gooley
Ted Gooley Fred Hutchinson Cancer Research Center
Mary E.D. Flowers
Mary E.D. Flowers Fred Hutchinson Cancer Research Center
Jean E. Sanders
Jean E. Sanders Fred Hutchinson Cancer Research Center
Robert P. Witherspoon
Robert P. Witherspoon Fred Hutchinson Cancer Research Center
Richard A. Nash
Richard A. Nash Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees and career pathways can open doors to dynamic opportunities in the healthcare field beyond traditional medical study. One popular choice is an online bachelor's degree in nutrition, perfect for those interested in dietary health, wellness, and preventive medicine.

For those drawn to leadership or administration, consider cahme-accredited online mha programs. These programs train future healthcare managers, preparing graduates for roles in hospitals, clinics, or public health organizations.

Registered Nurses (RNs) can advance their credentials rapidly with online rn to bsn programs no clinicals, combining convenience with streamlined learning for enhanced career prospects in nursing.

Advanced practice nurses or those wishing to pursue the highest level of clinical education may explore dnp programs online. These flexible options prepare nurses for leadership in practice, research, and healthcare policy.

Best Scientists Citing H. Joachim Deeg

Trending Scientists

Recently Published Articles